Avalo Therapeutics Financials

AVTX Stock  USD 7.66  0.56  6.81%   
Based on the key indicators related to Avalo Therapeutics' liquidity, profitability, solvency, and operating efficiency, Avalo Therapeutics is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.
  
Understanding current and past Avalo Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Avalo Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Avalo Therapeutics' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Avalo Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Avalo Therapeutics. Check Avalo Therapeutics' Beneish M Score to see the likelihood of Avalo Therapeutics' management manipulating its earnings.

Avalo Therapeutics Stock Summary

Avalo Therapeutics competes with AnaptysBio, Arcellx, Structure Therapeutics, Aerovate Therapeutics, and Alx Oncology. Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland. Cerecor operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 42 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS05338F3064
CUSIP15671L109 05338F108 05338F207 05338F306 15671L208
LocationMaryland; U.S.A
Business Address540 Gaither Road,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.avalotx.com
Phone410 522 8707
CurrencyUSD - US Dollar

Avalo Therapeutics Key Financial Ratios

Avalo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Avalo Therapeutics's current stock value. Our valuation model uses many indicators to compare Avalo Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avalo Therapeutics competition to find correlations between indicators driving Avalo Therapeutics's intrinsic value. More Info.
Avalo Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avalo Therapeutics' earnings, one of the primary drivers of an investment's value.

Avalo Therapeutics Systematic Risk

Avalo Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Avalo Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Avalo Therapeutics correlated with the market. If Beta is less than 0 Avalo Therapeutics generally moves in the opposite direction as compared to the market. If Avalo Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Avalo Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Avalo Therapeutics is generally in the same direction as the market. If Beta > 1 Avalo Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.

Steps to analyze company Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Avalo Therapeutics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Avalo has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Avalo Therapeutics' financials are consistent with your investment objective using the following steps:
  • Review Avalo Therapeutics' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Avalo Therapeutics' liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Avalo Therapeutics' financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Avalo Therapeutics' stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Avalo Therapeutics March 22, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Avalo Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Avalo Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Avalo Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Avalo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Avalo Therapeutics's daily price indicators and compare them against related drivers.

Additional Tools for Avalo Stock Analysis

When running Avalo Therapeutics' price analysis, check to measure Avalo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avalo Therapeutics is operating at the current time. Most of Avalo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avalo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avalo Therapeutics' price. Additionally, you may evaluate how the addition of Avalo Therapeutics to your portfolios can decrease your overall portfolio volatility.